Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedOct 19, 2024
DataAggregated Company Financials
Companies5
  • 7D0.3%
  • 3M-10.9%
  • 1Y6.8%
  • YTD-2.4%

Over the last 7 days, the Biotech industry has remained flat, although notably Zealand Pharma gained 4.6%. As for the the longer term, the industry is up 6.8% over the past 12 months. Earnings are forecast to grow by 16% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 20 Oct 2024DKK 174.2bDKK 25.5bDKK 5.5b21x31.8x6.8x
Tue, 17 Sep 2024DKK 198.1bDKK 25.5bDKK 5.5b24x36.2x7.8x
Thu, 15 Aug 2024DKK 198.2bDKK 26.0bDKK 5.7b19.2x34.7x7.6x
Sat, 13 Jul 2024DKK 197.3bDKK 24.8bDKK 5.6b17.7x35x8x
Mon, 10 Jun 2024DKK 179.2bDKK 24.8bDKK 5.6b18.5x31.8x7.2x
Wed, 08 May 2024DKK 184.3bDKK 25.2bDKK 6.2b16.2x29.9x7.3x
Fri, 05 Apr 2024DKK 188.4bDKK 23.9bDKK 5.0b19.7x37.4x7.9x
Sun, 03 Mar 2024DKK 184.8bDKK 22.8bDKK 4.3b23.5x43.2x8.1x
Tue, 30 Jan 2024DKK 168.1bDKK 23.3bDKK 4.2b23x40.4x7.2x
Thu, 28 Dec 2023DKK 176.2bDKK 23.3bDKK 4.2b25.9x42.3x7.6x
Sat, 25 Nov 2023DKK 172.7bDKK 23.3bDKK 4.2b25x41.5x7.4x
Mon, 23 Oct 2023DKK 162.9bDKK 22.0bDKK 4.7b18.9x34.4x7.4x
Wed, 20 Sep 2023DKK 199.5bDKK 22.0bDKK 4.7b23.4x42.1x9.1x
Fri, 18 Aug 2023DKK 188.2bDKK 20.6bDKK 3.9b35.9x48.6x9.1x
Sun, 16 Jul 2023DKK 200.5bDKK 19.5bDKK 4.4b40.9x45.5x10.3x
Tue, 13 Jun 2023DKK 209.4bDKK 19.5bDKK 4.4b44.7x47.5x10.7x
Thu, 11 May 2023DKK 207.4bDKK 18.6bDKK 3.9b33.7x53.8x11.1x
Sat, 08 Apr 2023DKK 199.2bDKK 17.9bDKK 3.5b31x56.3x11.1x
Mon, 06 Mar 2023DKK 197.5bDKK 17.9bDKK 3.5b30.4x55.7x11x
Wed, 01 Feb 2023DKK 201.9bDKK 14.7bDKK 3.3b30.9x61.7x13.7x
Fri, 30 Dec 2022DKK 220.4bDKK 14.7bDKK 3.3b34.3x67.3x15x
Sun, 27 Nov 2022DKK 234.0bDKK 14.7bDKK 3.3b36.6x71.5x15.9x
Tue, 25 Oct 2022DKK 202.7bDKK 12.4bDKK 1.5b44.8x133.5x16.3x
Thu, 22 Sep 2022DKK 194.6bDKK 12.4bDKK 1.5b43x130.7x15.7x
Sat, 20 Aug 2022DKK 207.0bDKK 12.2bDKK 1.6b44x131.4x16.9x
Mon, 18 Jul 2022DKK 188.1bDKK 11.1bDKK 130.5m69.8x1441.3x17x
Wed, 15 Jun 2022DKK 147.3bDKK 11.1bDKK 130.5m54.3x1128.9x13.3x
Fri, 13 May 2022DKK 147.9bDKK 10.7bDKK 622.4m44.8x237.7x13.8x
Sun, 10 Apr 2022DKK 184.1bDKK 10.7bDKK 622.4m55.7x295.8x17.2x
Tue, 08 Mar 2022DKK 158.7bDKK 10.7bDKK 525.4m48x302.1x14.8x
Thu, 03 Feb 2022DKK 171.6bDKK 9.8bDKK 117.9m52.6x1455.1x17.5x
Sat, 01 Jan 2022DKK 198.5bDKK 9.8bDKK 117.9m59.9x1683x20.2x
Mon, 29 Nov 2021DKK 197.6bDKK 9.8bDKK 117.9m59.1x1675.3x20.1x
Wed, 27 Oct 2021DKK 223.0bDKK 9.3b-DKK 169,922,000.0076.6x-1312.3x24x
Price to Earnings Ratio

-1312.3x


Total Market Cap: DKK 223.0bTotal Earnings: -DKK 169,922,000.00Total Revenue: DKK 9.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 209.1x202220232024
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 31.8x which is lower than its 3-year average PE of 208x.
  • The 3-year average PS ratio of 12.2x is higher than the industry's current PS ratio of 6.8x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 40% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-0.92%
Healthcare-1.22%
Biotech0.25%
Biotech0.25%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ZEAL Zealand PharmaDKK 804.004.6%
+DKK 2.5b		171.1%PS155x
BAVA Bavarian NordicDKK 217.102.9%
+DKK 479.1m		65.9%PE24.1x
BIOPOR BioPortoDKK 1.871.6%
+DKK 12.9m		19.3%PS23.7x
ORPHA OrphazymeDKK 1.24k2.0%
+DKK 1.0m		35.2%PB3.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ZEAL

DKK 804.00

Zealand Pharma

7D

4.6%

1Y

171.1%

BAVA

DKK 217.10

Bavarian Nordic

7D

2.9%

1Y

65.9%

ORPHA

DKK 1,243.40

Orphazyme

7D

2.0%

1Y

35.2%

GMAB

DKK 1,563.50

Genmab

7D

-2.5%

1Y

-24.2%

The Price Is Right For Genmab A/S (CPH:GMAB)

Sep 19
The Price Is Right For Genmab A/S (CPH:GMAB)

BIOPOR

DKK 1.87

BioPorto

7D

1.6%

1Y

19.3%